These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 20978254)

  • 1. Effects of folic acid plus vitamin B12 vs placebo in myocardial infarction survivors.
    Mason JB; Baron JA
    JAMA; 2010 Oct; 304(16):1783; author reply 1783-4. PubMed ID: 20978254
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of homocysteine-lowering with folic acid plus vitamin B12 vs placebo on mortality and major morbidity in myocardial infarction survivors: a randomized trial.
    ; Armitage JM; Bowman L; Clarke RJ; Wallendszus K; Bulbulia R; Rahimi K; Haynes R; Parish S; Sleight P; Peto R; Collins R
    JAMA; 2010 Jun; 303(24):2486-94. PubMed ID: 20571015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer incidence and mortality after treatment with folic acid and vitamin B12.
    Ebbing M; Bønaa KH; Nygård O; Arnesen E; Ueland PM; Nordrehaug JE; Rasmussen K; Njølstad I; Refsum H; Nilsen DW; Tverdal A; Meyer K; Vollset SE
    JAMA; 2009 Nov; 302(19):2119-26. PubMed ID: 19920236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin B12, folic acid, and the prevention of dementia.
    Clarke R
    N Engl J Med; 2006 Jun; 354(26):2817-9. PubMed ID: 16807420
    [No Abstract]   [Full Text] [Related]  

  • 5. Folic Acid and Vitamin B12 Supplementation and the Risk of Cancer: Long-term Follow-up of the B Vitamins for the Prevention of Osteoporotic Fractures (B-PROOF) Trial.
    Oliai Araghi S; Kiefte-de Jong JC; van Dijk SC; Swart KMA; van Laarhoven HW; van Schoor NM; de Groot LCPGM; Lemmens V; Stricker BH; Uitterlinden AG; van der Velde N
    Cancer Epidemiol Biomarkers Prev; 2019 Feb; 28(2):275-282. PubMed ID: 30341095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homocysteine lowering and cardiovascular events after acute myocardial infarction.
    Bønaa KH; Njølstad I; Ueland PM; Schirmer H; Tverdal A; Steigen T; Wang H; Nordrehaug JE; Arnesen E; Rasmussen K;
    N Engl J Med; 2006 Apr; 354(15):1578-88. PubMed ID: 16531614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperhomocysteinemia in a cohort of young patients with acute myocardial infarction from Western India: pattern of response to oral folic acid, vitamin B12, B6 therapy.
    Ghosh K; Khare A; Shetty S; Kulkarni B
    Clin Chim Acta; 2007 Feb; 377(1-2):281-2. PubMed ID: 17069780
    [No Abstract]   [Full Text] [Related]  

  • 8. Vitamin supplements and cardiovascular risk: review of the randomized trials of homocysteine-lowering vitamin supplements.
    Clarke R; Armitage J
    Semin Thromb Hemost; 2000; 26(3):341-8. PubMed ID: 11011852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homocysteine, B vitamins, and cardiovascular disease.
    Quinlivan EP; Gregory JF
    N Engl J Med; 2006 Jul; 355(2):206; author reply 209-11. PubMed ID: 16838446
    [No Abstract]   [Full Text] [Related]  

  • 10. Homocysteine, B vitamins, and cardiovascular disease.
    Tomlinson DR; Lang D; Lewis MJ
    N Engl J Med; 2006 Jul; 355(2):209; author reply 209-11. PubMed ID: 16838444
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy of folate and vitamin B12 in lowering homocysteine concentrations in hemodialysis patients.
    Azadibakhsh N; Hosseini RS; Atabak S; Nateghiyan N; Golestan B; Rad AH
    Saudi J Kidney Dis Transpl; 2009 Sep; 20(5):779-88. PubMed ID: 19736473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homocysteine, B vitamins, and cardiovascular disease.
    Khare A; Lopez M; Gogtay J
    N Engl J Med; 2006 Jul; 355(2):206; author reply 209-11. PubMed ID: 16848015
    [No Abstract]   [Full Text] [Related]  

  • 13. Homocysteine, B vitamins, and cardiovascular disease.
    Refsum H; Smith AD
    N Engl J Med; 2006 Jul; 355(2):207; author reply 209-11. PubMed ID: 16848014
    [No Abstract]   [Full Text] [Related]  

  • 14. Homocysteine, B vitamins, and cardiovascular disease.
    Wang X; Demirtas H; Xu X
    N Engl J Med; 2006 Jul; 355(2):207-9; author reply 209-11. PubMed ID: 16838445
    [No Abstract]   [Full Text] [Related]  

  • 15. Plasma homocysteine level and myocardial infarction: how high is high enough to need intervention?
    Ghosh K
    South Med J; 2006 Aug; 99(8):796-7. PubMed ID: 16929868
    [No Abstract]   [Full Text] [Related]  

  • 16. Homocysteine, B vitamins, and cardiovascular disease.
    de Craen AJ; Stott DJ; Westendorp RG
    N Engl J Med; 2006 Jul; 355(2):205-6; author reply 209-11. PubMed ID: 16837687
    [No Abstract]   [Full Text] [Related]  

  • 17. Assessing cancer prevention studies--a matter of time.
    Drake BF; Colditz GA
    JAMA; 2009 Nov; 302(19):2152-3. PubMed ID: 19920243
    [No Abstract]   [Full Text] [Related]  

  • 18. [Should patients with chronic renal insufficiency be treated with folic acid, vitamin B6 and vitamin B12?].
    Birn H
    Ugeskr Laeger; 2008 Mar; 170(11):933-7. PubMed ID: 18397619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folate therapy and in-stent restenosis after coronary stenting.
    Lange H; Suryapranata H; De Luca G; Börner C; Dille J; Kallmayer K; Pasalary MN; Scherer E; Dambrink JH
    N Engl J Med; 2004 Jun; 350(26):2673-81. PubMed ID: 15215483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Status of homocysteine reduction in prevention of cardiovascular diseases. HOPE-2 study (Heart Outcomes Prevention Evaluation)].
    Strasser RH
    Internist (Berl); 2007 Mar; 48(3):327-9. PubMed ID: 17333057
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.